Literature DB >> 25170215

Role of the ¹³C-methacetin breath test in the assessment of acute liver injury in a rat model.

Dong Zhu1, Hui Zhang1, Jing-Yi Mao1, Hong-Yan Wang1, Xin Li1, You-Qing Xu1.   

Abstract

AIM: To evaluate the role of the (13)C-methacetin breath test ((13)C-MBT) in the assessment of acute liver injury in a rat model.
METHODS: Acute liver injury in rats was induced by a single intraperitoneal injection of D-galactosamine (D-GalN). Forty-eight male Sprague-Dawley rats were randomly assigned to a control group (n = 8) and five model groups (each n = 8), and acute liver injury was assessed at different time points (6, 12, 24, 48 and 72 h) after D-GalN injection. The (13)C-MBT, biochemical tests, 15-min retention rate of indocyanine green (ICGR15), and liver biopsy were performed and compared between the control and model groups. Correlations between parameters of the (13)C-MBT (Tmax, MVmax, CUM₁₂₀ and DOBmax), biochemical tests, ICGR15 and liver necrosis score were also analyzed using Spearman's correlation analysis.
RESULTS: Tmax, MVmax, CUM₁₂₀ and DOBmax, as well as most of the traditional methods, correlated with the liver necrosis score (r = 0.493, P < 0.05; r = -0.731, P < 0.01; r = -0.618, P < 0.01; r = -0.592, P < 0.01, respectively). MVmax, CUM₁₂₀ and DOBmax rapidly decreased and were lower than those in the controls as early as 6 h after D-GalN injection (3.84 ± 0.84 vs 5.06 ± 0.78, P < 0.01; 3.35 ± 0.72 vs 4.21 ± 1.44, P < 0.05; 52.3 ± 20.58 vs 75.1 ± 9.57, P < 0.05, respectively) and reached the lowest point 24 h after D-GalN injection. MVmax, CUM₁₂₀ and DOBmax returned to normal levels 72 h after D-GalN injection and preceded most of the traditional methods, including liver biopsy.
CONCLUSION: The (13)C-MBT is a sensitive tool for the timely detection of acute liver injury and early prediction of recovery in a rat model. Further clinical studies are warranted to validate its role in patients with acute liver injury.

Entities:  

Keywords:  13C-methacetin breath test; Acute liver injury; Animal model; Liver function

Mesh:

Substances:

Year:  2014        PMID: 25170215      PMCID: PMC4145769          DOI: 10.3748/wjg.v20.i32.11305

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Plasma disappearance rate of indocyanine green in liver dysfunction.

Authors:  P Faybik; H Hetz
Journal:  Transplant Proc       Date:  2006-04       Impact factor: 1.066

2.  Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.

Authors:  E Giannini; P Romagnoli; A Fasoli; B Chiarbonello; F Malfatti; F Botta; D Risso; P B Lantieri; V Savarino; R Testa
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

3.  ¹³C-methacetin breath test in the evaluation of disease severity in patients with liver cirrhosis.

Authors:  Jana Vranova; Miluse Hendrichova; Hana Kolarova; Karolina Kratka; Jozef Rosina; Jiri Horak
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2013-03-22       Impact factor: 1.245

4.  Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Authors:  D Festi; S Capodicasa; L Sandri; L Colaiocco-Ferrante; T Staniscia; E Vitacolonna; A Vestito; P Simoni; G Mazzella; P Portincasa; E Roda; A Colecchia
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

5.  C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations.

Authors:  Anna Kasicka-Jonderko; Anna Nita; Krzysztof Jonderko; Magdalena Kamińska; Barbara Błońska-Fajfrowska
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

6.  Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.

Authors:  Deha Erdogan; Bob H M Heijnen; Roelof J Bennink; Mariël Kok; Sander Dinant; Irene H Straatsburg; Dirk J Gouma; Thomas M van Gulik
Journal:  Liver Int       Date:  2004-04       Impact factor: 5.828

7.  Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant.

Authors:  Salem M Bazarah; Kevork M Peltekian; Vivian C McAlister; Heinrich Bitter-Suermann; Alan S MacDonald
Journal:  Clin Invest Med       Date:  2004-08       Impact factor: 0.825

8.  13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry.

Authors:  O Goetze; N Selzner; H Fruehauf; M Fried; T Gerlach; B Mullhaupt
Journal:  Aliment Pharmacol Ther       Date:  2007-07-15       Impact factor: 8.171

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Diagnostic value of the C methacetin breath test in various stages of chronic liver disease.

Authors:  Hamizah Razlan; Nurhayaty Muhamad Marzuki; Mei-Ling Sharon Tai; Azhar-Shah Shamsul; Tze-Zen Ong; Sanjiv Mahadeva
Journal:  Gastroenterol Res Pract       Date:  2011-06-07       Impact factor: 2.260

View more
  1 in total

1.  A novel variant of the 13C-methacetin liver function breath test that eliminates the confounding effect of individual differences in systemic CO2 kinetics.

Authors:  Hermann-Georg Holzhütter; Tilo Wuensch; Robert Gajowski; Nikolaus Berndt; Sascha Bulik; David Meierhofer; Martin Stockmann
Journal:  Arch Toxicol       Date:  2020-02-04       Impact factor: 5.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.